Daclatasvir, an NS5A Replication Complex Inhibitor, Combined With Peginterferon Alfa-2a and Ribavirin in Treatment-Naive HCV-Genotype 1 or 4 Subjects: Phase 2b COMMAND-1 SVR12 Results Christophe Hezode , Gideon M. Hirschfield , Wayne Ghesquiere , William Sievert , Maribel Rodriguez-Torres , Stephen D. Shafran , Paul J. Thuluvath , Harvey A. Tatum , Imam Waked , Gamal E. Esmat , Eric Lawitz , Vinod K. Rustgi , Stanislas Pol , Nina Weis , Paul Pockros , Marc Bourliere , Lawrence Serfaty , John M. Vierling , Michael W. Fried , Ola Weiland , Maurizia R. Brunetto , Gregory T. Everson , Stefan Zeuzem , Paul Y. Kwo , Mark S. Sulkowski , Norbert Brau , Megan Wind-Rotolo , Zhaohui Liu , Eric A. Hughes , Steven M. Schnittman , Philip D. Yin HEPATOLOGY(2012)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper